References
- Particle Therapy Co-Operative Group 2020. [cited 2020 Jul 1]. Available from: https://ptcog.ch.
- Brandal P, Bergfeldt K, Aggerholm Pedersen N, et al. A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients. Acta Oncol. 2020; In press.
- Glimelius B, Ask A, Bjelkengren G, et al. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44(8):836–849.
- Toma-Dasu J, Dasu A, Vestergaard A, et al. RBE for proton radiation therapy – a Nordic view in the international perspective. Acta Oncol. 2020; In press.
- Ohlsson-Nevo E, Furberg M, Giørtz M, et al. Patients’ perspective in the context of proton beam therapy: summary of a Nordic workshop. Acta Oncol. 2020; In press. DOI:10.1080/0284186X.2020.1762927
- Witt Nyström P, Bratland Å, Minn H, et al. Ongoing and future clinical trials in particle therapy in the Nordic countries. Acta Oncol. 2020; In press. DOI:10.1080/0284186X.2020.1792548
- Langendijk J, Orecchia R, Haustermans K, et al. Prospective data registration and clinical trials for particle therapy in Europe. Radiother Oncol. 2018;128(1):9–13.